Clinical Trial Update: Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel

View source ↗

Summary

A clinical trial investigating biomarkers related to muscle and joint pain in patients with solid tumors receiving paclitaxel has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Arthralgia, Pain | Status: TERMINATED